MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-UK-06-0002825
Badrivas Biotech Private Limited
Badrivas Biotech Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹10.88 Cr
▲ 22% YoY
Net profit · FY 2025
₹7.42 Lakh
Net margin 0.7%
EBITDA · FY 2025
₹41.95 Lakh
EBITDA margin 3.9%
Authorised capital
₹60 Lakh
Registered with MCA
Paid-up capital
₹53.95 Lakh
Issued & subscribed
Open charges
₹4.72 Cr
Secured borrowings
Company age
21 yrs
Est. 2005
Employees · EPFO
6
Provident fund records
About Badrivas Biotech Private Limited
Data last updated:
Badrivas Biotech Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 14 January 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74920DL2005PTC132140. Its GSTIN is 05AACCB5391A1Z5 (Uttarakhand).
The company has an authorised share capital of ₹60 Lakh and a paid-up capital of ₹53.95 Lakh. It is led by directors including Praveen Kumar and Yoginder Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. 468 – B Tara Gagar Kakrola Uttam Nagar, New Delhi, Delhi, India – 110043.
As per the financials filed for FY 2025, the company reported a revenue of ₹10.88 Cr, a growth of 22% compared to the previous year. For the same year it recorded a net profit of ₹7.42 Lakh (net margin 0.7%) and EBITDA of ₹41.95 Lakh (EBITDA margin 3.9%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 3% over five years.
The company has about 6 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Badrivas Biotech. As per MCA filings, the company has open charges of ₹4.72 Cr on record. Court records list 10 cases involving the company, including 7 filed by the company and 3 filed against it; 5 cases are pending.
Badrivas Biotech Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-UK-06-0002825). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U74920DL2005PTC132140
Registration Number 132140
Incorporation Date 14 January 2005
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-UK-06-0002825
Recognitions & Rankings of Badrivas Biotech
Contact details
Badrivas Biotech Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot No. 468 – B Tara Gagar Kakrola Uttam Nagar, New Delhi, Delhi, India – 110043
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Badrivas Biotech Private Limited, buy the company report.
Comprehensive company report
Badrivas Biotech Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Badrivas Biotech operates one associated brand: Badrivas Biotech. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| A pharmaceutical company manufacturing tablets, capsules, oral liquids, ointments, and providing third-party services. | badrivasbiotech.com |
Business activity
The main business activity of Badrivas Biotech is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Badrivas Biotech Private Limited, buy the company report.
Financials of Badrivas Biotech Private Limited
FY 2025 filings availableBadrivas Biotech Private Limited reported revenue of ₹10.88 Cr (up 22% YoY) for FY 2025.
Revenue · FY 2025
₹10.88 Cr ▲ 22%
Net profit · FY 2025
₹7.42 Lakh margin 0.7%
EBITDA · FY 2025
₹41.95 Lakh margin 3.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 22%
3 years · compounded
▼ 2%
5 years · compounded
▲ 3%
EBITDA CAGR growth
1 year
▲ 17%
3 years · compounded
▲ 10%
5 years · compounded
▲ 9%
Revenue has grown at a compounded annual rate (CAGR) of 3% over five years, including 22% growth in the latest year. EBITDA rose 17% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹41.95 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹7.42 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.9% | ||||
| Net Profit Margin | 0.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Badrivas Biotech Private Limited, buy the company report.
Board of directors of Badrivas Biotech Private Limited
Badrivas Biotech has 3 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Praveen Kumar | Director | 07 Feb 2024 | 2 Years 8 Months | Current |
| Yoginder Singh | Director | 20 Nov 2024 | 1 Years 11 Months | Current |
| Ashok Kumar | Director | 12 Feb 2025 | 1 Years 8 Months | Current |
Peer comparison
Badrivas Biotech Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Gary Pharmaceuticals Private Limited | ₹10.9 Cr (FY 2024) | -6.0% | Ludhiana, Punjab, India | |||
| Badrivas Biotech Private Limitedthis company | ₹10.88 Cr (FY 2025) | ₹7.42 Lakh | 0.7% | 22.0% | 6 | New Delhi, Delhi, India |
| A.N.Pharmacia Laboratories Pvt Ltd. | ₹10.84 Cr (FY 2022) | 1.0% | Kolkata, West Bengal, India | |||
| G.D. Laboratories (India) Private Limited | ₹10.81 Cr (FY 2024) | -6.0% | New Delhi, Delhi, India |
To see the full peer comparison of Badrivas Biotech Private Limited, buy the company report.
Auditor
Badrivas Biotech Private Limited is audited by P S SETHI & CO. for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| P S SETHI & CO. | FY 2024 | 004545C |
Shareholding
The shareholding of Badrivas Biotech Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Badrivas Biotech Private Limited, buy the company report.
Charges & borrowings
Open charges
₹4.72 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 24 Oct 2024 | 101020230 | Sidbi | ₹1.36 Cr | Open | |
| 24 Nov 2023 | 100866639 | Indian Overseas Bank | ₹13.5 Lakh | Open | |
| 21 Sep 2021 | 100483574 | Sidbi | ₹1 Cr | Open | |
| 13 Jul 2020 | 100358630 | Sidbi | ₹4.53 Lakh | Open | |
| 22 Sep 2018 | 100215523 | Sidbi | ₹24 Lakh | Open |
To see the full charge records of Badrivas Biotech Private Limited, buy the company report.
Total charge records: 6 View all charges
Legal cases
Badrivas Biotech Private Limited has 10 court cases on record: 7 filed by Badrivas Biotech, 3 filed against it. 5 cases are pending and 5 are disposed.
Total cases
10
Filed by the company
7
Filed against the company
3
Pending
5
Disposed
5
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 6 | 3 | 3 |
| High courts | 3 | 0 | 2 |
| Supreme Court | 1 | 0 | 0 |
Cases on record (5 of 10)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, RAICHUR, Karnataka | Criminal complaint | Filed against the company by State at the Instance of Asst Drugs Controller, Raichur | Pending |
| District court, Dehradun, Uttarakhand | Commercial suit | Filed by the company against M/S Sunzenixx | Pending |
| Allahabad High Court | Writ petition | Filed by the company against State of U.P. Thru. Prin. Secy. Deptt. Medical Health and Family Welfare Lko. and 4 Others | Pending |
| High Court of Delhi | Court case (CS(OS)) | Filed by the company against an individual | Pending |
| District court, Mahabubabad, Telangana | Criminal complaint | Filed against the company by an individual | Pending |
To see the full case history of Badrivas Biotech Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Badrivas Biotech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Badrivas Biotech Private Limited has a workforce of 6 employees on its EPFO records as of Mar 31, 2025, across 1 active EPFO establishment.
Employee count
6
Active EPFO establishments
1
Employee growth
-14.29%
GST
Badrivas Biotech has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 05AACCB5391A1Z5 | Uttarakhand | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Badrivas Biotech Private Limited, buy the company report.
Recent activity
Badrivas Biotech Private Limited has 9 board changes on record since 2016: 3 appointments and 6 cessations. The latest: Ashok Kumar ceased to be Additional Director on 29 Sep 2025.
AGM
Badrivas Biotech Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Ceased
Ashok Kumar ceased to be Additional Director.
Filing
Badrivas Biotech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Appointed
Ashok Kumar was appointed as Director.
Appointed
Yoginder Singh was appointed as Director.
Charges
A charge with Sidbi amounted to Rs. 136.20 Lakh with Charge ID 101020230 was registered on 24 Oct 2024.
Ceased
Praveen Kumar ceased to be Additional Director.
Appointed
Praveen Kumar was appointed as Director.
Charges
A charge with Indian Overseas Bank amounted to Rs. 13.50 Lakh with Charge ID 100866639 was registered on 24 Nov 2023.
Charges
A charge with Indian Overseas Bank of Rs. 194.00 Lakh registered on 15 Apr 2008 with Charge ID 10105019 was modified on 29 Oct 2021.
Charges
A charge with Sidbi amounted to Rs. 100.00 Lakh with Charge ID 100483574 was registered on 21 Sep 2021.
Ceased
Drishika ceased to be Additional Director.
7 earlier events are in the company report.
Frequently asked questions
Badrivas Biotech is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 14 January 2005 (21+ years old) and is registered under CIN U74920DL2005PTC132140.
Badrivas Biotech has 3 current directors:
- Praveen Kumar - Director
- Yoginder Singh - Director
- Ashok Kumar - Director
The latest financial statements of Badrivas Biotech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Badrivas Biotech is 05AACCB5391A1Z5, registered in Uttarakhand.
The CIN (Corporate Identification Number) of Badrivas Biotech is U74920DL2005PTC132140. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Badrivas Biotech has 10 court cases on record: 7 filed by the company and 3 filed against it. 5 are pending. Most are in the district courts.
Badrivas Biotech was incorporated on 14 January 2005, making it 21+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Badrivas Biotech by revenue are Gary Pharmaceuticals Private Limited, A.N.Pharmacia Laboratories Pvt Ltd, G.D. Laboratories (India) Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Ashok Kumar ceased to be Additional Director on 29 Sep 2025. Ashok Kumar was appointed as Director on 12 Feb 2025. Yoginder Singh was appointed as Director on 20 Nov 2024. Badrivas Biotech has 9 board changes on record in total.
Yes, Badrivas Biotech is registered as a small enterprise under Udyam registration (number: UDYAM-UK-06-0002825).
The registered office of Badrivas Biotech is at Plot No. 468 – B Tara Gagar Kakrola Uttam Nagar, New Delhi, Delhi, India – 110043.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages